Page Tools:
  • print-friendly version

100 Questions & Answers About Hepatitis C: A Lahey Clinic Guide

Author(s): Stephen C. Fabry, MD, Lahey Clinic
R. Anand Narasimhan, MD, Lahey Clinic
Details:
  • ISBN-13: 9780763740771
  • ISBN-10:0763740772
  • Paperback    186 pages      © 2007
Price: International Sales $22.95 US List
Add to Cart

Overview

There are approximately 2.5 million cases of Hepatitis C in the United States and approximately 200 million worldwide. Whether you're a newly diagnosed patient, a friend or relative of someone with hepatitis C, this book offers help. Written by two prominent liver specialists from the Lahey Clinic Medical Center, this book provides authoritative, practical answers to the most common questions about hepatitis C, with important information on treatment and treatment side effects, alternative medical options and experimental drugs, natural history, including complications of hepatitis C, and much more.

ShowKey Features

Concise, easy-to-read paperback book

The question and answer format mimics an actual physician consultation

Written by an expert author team with extensive experience

Back to top

ShowTable of Contents

Dedication

Introduction

Foreword

Part 1:The Basics

Questions 1–8 provide background information for understanding hepatitis C,

including:

• Can you give me an overview of the liver and liver disease?

• What is hepatitis C?

• Who should be screened for hepatitis C?

Part 2:Transmission

Questions 9–17 address concerns about how hepatitis is transmitted and prevention,

including:

• What are the most common risk factors for hepatitis C?

• How can I prevent transmission of hepatitis C to other people?

• Can hepatitis C be spread through sexual contact

Part 3:Natural History and Symptoms

Questions 18–24 discuss symptoms and other factors associated with hepatitis C,

including:

• What is the natural history of hepatitis C?

• What are the signs and symptoms of hepatitis C infection?

• Can the liver worsen while someone feels well?

Part 4:Testing and Evaluation

Questions 25–36 cover available tests and methods for evaluation, including:

• Can you give me an overview of testing and evaluation?

• What is a hepatitis C antibody test?

• What is a direct test for hepatitis C virus?

Part 5:Treatment

Questions 37–50 explore treatment options and choices, including:

• Can you give me an overview of treatment?

• Can hepatitis C be cured, and how is “cure” defined?

• What are the potential benefits of undergoing treatment for hepatitis C?

Part 6:Treatment Side Effects

Questions 51–62 address common side effects associated with treatment, including:

• Are there any treatment side effects?

• What are the side effects of interferon therapy?

• What are the side effects of ribavirin therapy?

Part 7: Special Situations

Questions 63–68 help patients cope with special situations, including:

• What if I have a new case of acute hepatitis C infection?

• Is acute hepatitis C treated differently?

• What if I have mild kidney disease or even kidney failure?

Part 8: Complementary and Alternative Medicine Options

Questions 69–79 explore the role of complementary and alternative medicine

options, including:

• What is the role of complementary and alternative medicine options in hepatitis

C?

• What can you tell me about milk thistle?

• What can you tell me about licorice root?

Part 9: Cirrhosis

Questions 80–85 provide answers about cirrhosis as it relates to hepatitis C,

including:

• What is cirrhosis?

• How is cirrhosis diagnosed?

• What are the signs and symptoms of cirrhosis?

Part 10: Liver Cancer

Questions 86–91 answer common questions about liver cancer, including:

• Can you give me an overview of liver cancer and hepatitis C?

• What are the signs and symptoms of liver cancer?

• Who should be screened for liver cancer and how?

Part 11: Liver Transplantation

Questions 92–98 cover the risks, recurrence, and treatment before and after a liver

transplant, including:

• Can you give me an overview of liver transplantation for hepatitis C?

• How are patients ordered on the transplant list, and what is the MELD score?

• What are the risks of surgery, and what is the difference between deceased donor

and living donor liver transplantation?

Part 12:The Future

Questions 99 and 100 offer a candid account of the current rate of cure and reasons

for tremendous optimism for the future, including:

• Are there any new treatment options for hepatitis C?

• What should I expect in the future?

Resources

Glossary

Index


Back to top

ShowAbout the Author(s)

Stephen C. Fabry, MD-Lahey Clinic

Stephen C. Fabry, MD is a senior staff physician at Lahey Clinic in Massachusetts. He specializes in the treatment of patients with liver disease, including hepatitis C and evaluation for liver transplantation. Dr. Fabry graduated from New York University School of Medicine where he was elected to the Alpha Omega Honor Medical Society. He completed his medical residency at Beth Israel Hospital in Boston, Massachusetts and his gastroenterology fellowship at New England Medical Center in Boston, Massachusetts. His research interests include hepatitis C treatment and the management of patients with end stage liver disease.

R. Anand Narasimhan, MD-Lahey Clinic

R. Anand Narasimhan, MD is a fellow at Lahey Clinic in Massachusetts. He was raised in Kingston, Rhode Island. After earning his medical degree from the University of Vermont, he completed an internal medicine residency at Mayo Clinic in Rochester, Minnesota. He is currently finishing his fellowship in gastroenterology at Lahey Clinic. He has an interest in treating patients with liver disease.

Back to top

ShowReviews

  • "In this new book, Drs. Stephen Fabry and Anand Narasimhan, respected hepatologists with a long experience treating hepatitis C, provide patients with a place to turn.  They have done a remarkably thorough job of anticipating questions that patients diagnosed with hepatitis C should want to have answered and has answered each of them in a clear and concise fashion.  This book is essential reading for patients with hepatitis C who are seeking help in understanding their condition."

    -- from the foreword by Daniel S. Pratt, MD,

    Executive Director, Liver-Biliary-Pancreas Center

    Massachusetts General Hospital

    Harvard Medical School 

    "Dr. Fabry has produced a concise, thorough, and candid summary of the major questions about hepatitis C. He has effectively combined scientific evidence with clinical experience and compassion. Readers get direct, sound advice from a doctor they can trust."

    --Peter Bonis, MD
    Assistant Professor of Medicine
    Tufts University School of Medicine
    Assistant Director, Tufts Evidence-Based Practice Center

Back to top